Torthaí cuardaigh - Banasavadi-Siddegowda, Yeshavanth
- 1 - 20 toradh as 31 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
-
2
-
3
-
4
-
5
-
6
Pathological Features of Tumors of the Nervous System in Hereditary Cancer Predisposition Syndromes: A Review de réir Tadros, Saber, Kondrashov, Aleksei, Namagiri, Sriya, Chowdhury, Ashis, Banasavadi-Siddegowda, Yeshavanth Kumar, Ray-Chaudhury, Abhik
Foilsithe / Cruthaithe 2021Téacs -
7
Tumor-specific Activation of the c-JUN/MELK Pathway Regulates Glioma Stem Cell Growth in a p53-dependent Manner de réir Gu, Chunyu, Banasavadi-Siddegowda, Yeshavanth K, Joshi, Kaushal, Nakamura, Yuko, Kurt, Habibe, Gupta, Snehalata, Nakano, Ichiro
Foilsithe / Cruthaithe 2013Téacs -
8
Sex as a biological variable in response to temozolomide de réir Russell, Luke, Bolyard, Chelsea, Banasavadi-Siddegowda, Yeshavanth, Weiss, Alex, Zhang, Jianying, Shakya, Reena, Powell, Kimerly, Kaur, Balveen
Foilsithe / Cruthaithe 2017Téacs -
9
FKBP38 Peptidylprolyl Isomerase Promotes the Folding of Cystic Fibrosis Transmembrane Conductance Regulator in the Endoplasmic Reticulum de réir Banasavadi-Siddegowda, Yeshavanth K., Mai, Junbo, Fan, Yifei, Bhattacharya, Sumit, Giovannucci, David R., Sanchez, Edwin R., Fischer, Gunter, Wang, Xiaodong
Foilsithe / Cruthaithe 2011Téacs -
10
Human Heat Shock Protein 105/110 kDa (Hsp105/110) Regulates Biogenesis and Quality Control of Misfolded Cystic Fibrosis Transmembrane Conductance Regulator at Multiple Levels de réir Saxena, Anita, Banasavadi-Siddegowda, Yeshavanth K., Fan, Yifei, Bhattacharya, Sumit, Roy, Gargi, Giovannucci, David R., Frizzell, Raymond A., Wang, Xiaodong
Foilsithe / Cruthaithe 2012Téacs -
11
EXTH-26. PRMT5 AS A DRUGGABLE TARGET FOR GLIOBLASTOMA THERAPY de réir Banasavadi-Siddegowda, Yeshavanth Kumar, Welker, Alessandra M, Imitola, Jaime, Li, Chenglong, Zhang, Jianying, Beattie, Christine E, Baiocchi, Robert, Kaur, Balveen
Foilsithe / Cruthaithe 2017Téacs -
12
Humanized Chondroitinase ABC Sensitizes Glioblastoma Cells to Temozolomide de réir Jaime-Ramirez, Alena Cristina, Dmitrieva, Nina, Yoo, Ji Young, Banasavadi-Siddegowda, Yeshavanth, Zhang, Jianying, Relation, Theresa, Bolyard-Blessing, Chelsea, Wojton, Jeffrey, Kaur, Balveen
Foilsithe / Cruthaithe 2017Téacs -
13
STEM-16. DUAL INHIBITION OF PROTEIN ARGININE METHYLTRANSFERASE 5 AND PROTEIN PHOSPHATASE 2A ENHANCES THE ANTI-TUMOR EFFICACY IN PRIMARY GLIOBLASTOMA NEUROSPHERES de réir Sur, Hannah, Gangaplara, Arunakumar, Wang, Xiang, Ray-Chaudhury, Abhik, Zhuang, Zhengping, Kumar, Sachin, Heiss, John, Young Yoo, Ji, Kaur, Balveen, Kumar Banasavadi-Siddegowda, Yeshavanth
Foilsithe / Cruthaithe 2019Téacs -
14
Suppression of HMGB1 Released in the Glioblastoma Tumor Microenvironment Reduces Tumoral Edema de réir Hong, Bangxing, Muili, Kamaldeen, Bolyard, Chelsea, Russell, Luke, Lee, Tae Jin, Banasavadi-Siddegowda, Yeshavanth, Yoo, Ji Young, Yan, Yuanqing, Ballester, Leomar Y., Bockhorst, Kurt H., Kaur, Balveen
Foilsithe / Cruthaithe 2018Téacs -
15
STEM-03. WAVE1 KNOCKDOWN ENHANCES THE ANTITUMOR EFFICACY IN PRIMARY GLIOBLASTOMA NEUROSPHERES de réir Namagiri, Sriya, Thammegowda, Shilpa, Sur, Hannah, Vézina, Amélie, Chowdhury, Ashis, Maric, Dragan, Gangaplara, Arunakumar, Edwards, Nancy, Jackson, Sadhana, Ray-Chaudhury, Abhik, Heiss, John, Banasavadi-Siddegowda, Yeshavanth Kumar
Foilsithe / Cruthaithe 2020Téacs -
16
CSIG-17. PRMT5 INHIBITION SENSITIZES GLIOBLASTOMA MODELS TO TRAMETINIB TREATMENT de réir Otani, Yoshihiro, Namagiri, Sriya, Thammegowda, Shilpa, Sur, Hannah, Chowdhury, Ashis, Lewis, Cole, Shimizu, Toshihiko, Lee, Tae Jin, Maric, Dragan, Yoo, Ji Young, Heiss, John, Kaur, Balveen, Banasavadi-Siddegowda, Yeshavanth Kumar
Foilsithe / Cruthaithe 2020Téacs -
17
MELK-Dependent FOXM1 Phosphorylation is Essential for Proliferation of Glioma Stem Cells de réir Joshi, Kaushal, Banasavadi-Siddegowda, Yeshavanth, Mo, Xiaokui, Kim, Sung-Hak, Mao, Ping, Kig, Cenk, Nardini, Diana, Sobol, Robert W, Chow, Lionel ML, Kornblum, Harley I, Waclaw, Ronald, Beullens, Monique, Nakano, Ichiro
Foilsithe / Cruthaithe 2013Téacs -
18
PRMT5 as a druggable target for glioblastoma therapy de réir Banasavadi-Siddegowda, Yeshavanth Kumar, Welker, Alessandra M, An, Min, Yang, Xiaozhi, Zhou, Wei, Shi, Guqin, Imitola, Jaime, Li, Chenglong, Hsu, Sigmund, Wang, Jiang, Phelps, Mitch, Zhang, Jianying, Beattie, Christine E, Baiocchi, Robert, Kaur, Balveen
Foilsithe / Cruthaithe 2018Téacs -
19
Differential expression of an endogenous retroviral element [HERV-K(HML-6)] is associated with reduced survival in glioblastoma patients de réir Shah, Ashish H., Govindarajan, Vaidya, Doucet-O’Hare, Tara T., Rivas, Sarah, Ampie, Leo, DeMarino, Catherine, Banasavadi-Siddegowda, Yeshavanth Kumar, Zhang, Yong, Johnson, Kory R., Almsned, Fahad, Gilbert, Mark R., Heiss, John D., Nath, Avindra
Foilsithe / Cruthaithe 2022Téacs -
20
TAMI-11. IMPACT OF oHSV ACTIVATED NOTCH SIGNALING IN TUMOR MICROENVIRONMENT, AND ITS IMPACT ON ANTI-TUMOR IMMUNITY de réir Otani, Yoshihiro, Yoo, Ji Young, Chao, Samantha, Shimizu, Toshihiko, Lewis, Cole, Murphy, Sara, Pineda, Josue, Caraballo, Kimberly Rivera, Hong, Bangxing, Banasavadi-Siddegowda, Yeshavanth Kumar, Heiss, John, Yan, Yuanqing, Olson, Scott, Pei, Guangsheng, Zhao, Zhongming, Kaur, Balveen
Foilsithe / Cruthaithe 2020Téacs